Evidence map›Paper›PMID 35158012›Full record

ArticleAmerican journal of infection control2022

Strategies utilized to prevent and control SARS-CoV-2 transmission in two congregate, psychiatric healthcare settings during the pandemic.

Katherine M Schultz, Pamela Blair Miller, Lisa Stancill, Lauren M DiBiase, Shelley Ashcroft, Barbara-Ann Bybel, Gary J Gala, Kenan M Penaskovic, Paul Perryman, Lisa Teal and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katherine M SchultzDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC. Electronic address: katherine.schultz@unchealth.unc.edu.
Pamela Blair MillerDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
Lisa StancillDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
Lauren M DiBiaseDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC; Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC.
Shelley AshcroftDepartment of Inpatient Psychiatry Services, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
Barbara-Ann BybelDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC.
Gary J GalaDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC.
Kenan M PenaskovicDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC.
Paul PerrymanDepartment of Inpatient Psychiatry Services, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
Lisa TealDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
David J WeberDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC.
David WitekDepartment of Inpatient Psychiatry Services, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC.
Michael N ZarzarDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC.
Emily Sickbert-BennettDepartment of Infection Prevention, University of North Carolina at Chapel Hill Medical Center, Chapel Hill, NC; Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has had a substantial effect on the delivery of psychiatric health care. Inpatient psychiatric health care facilities have experienced outbreaks of COVID-19, making these areas particularly vulnerable.

methodsOur facility used a multidisciplinary approach to implement enhanced infection prevention and control (IPC) interventions in our psychiatric health care areas.

resultsIn a 16-month period during the COVID-19 pandemic, our 2 facilities provided >29,000 patient days of care to 1,807 patients and identified only 47 COVID-19 positive psychiatric health inpatients (47/1,807, or 2.6%). We identified the majority of these cases by testing all patients at admission, preventing subsequent outbreaks. Twenty-one psychiatric health care personnel were identified as COVID+ during the same period, with 90% linked to an exposure other than a known positive case at work. DISCUSSION: The IPC interventions we implemented provided multiple layers of safety for our patients and our staff. Ultimately, this resulted in low SARS-CoV-2 infection rates within our facilities.

conclusionsPsychiatric health care facilities are uniquely vulnerable to COVID-19 outbreaks because they are congregate units that promote therapeutic interactions in shared spaces. IPC interventions used in acute medical care settings can also work effectively in psychiatric health care, but often require modifications to ensure staff and patient safety.

Indexed as

COVID-19PandemicsDelivery of Health CareHumansInfection ControlSARS-CoV-2Infection controlInfection preventionIsolation precautionsMental healthSARS-CoV-2

Identifiers

PMID35158012
PMCPMC8832849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.